Overview

A Study of TAK-227 in Healthy Adults

Status:
Not yet recruiting
Trial end date:
2023-08-07
Target enrollment:
Participant gender:
Summary
The main aim of this study is to test the effects of food consumption with sponsor compound TAK-227 in healthy participants. The study will also measure side effects, and to check how much TAK-227 stays in the blood over time to work out the best dose.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda